| Code | Description | Claims | Beneficiaries | Total Paid |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
2,439 |
1,668 |
$1.84M |
| J9271 |
Injection, pembrolizumab, 1 mg |
55 |
49 |
$614K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,697 |
12,502 |
$464K |
| Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg |
195 |
145 |
$332K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
681 |
460 |
$290K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,978 |
2,867 |
$220K |
| J0897 |
Injection, denosumab, 1 mg |
133 |
131 |
$204K |
| Q5130 |
Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg |
117 |
79 |
$158K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,902 |
3,797 |
$150K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,924 |
3,062 |
$147K |
| 99215 |
Prolong outpt/office vis |
2,295 |
2,048 |
$105K |
| 96367 |
|
2,439 |
1,523 |
$92K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,800 |
3,622 |
$84K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
920 |
919 |
$62K |
| 99205 |
Prolong outpt/office vis |
787 |
786 |
$56K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,228 |
2,315 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,213 |
2,375 |
$38K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,388 |
828 |
$26K |
| 96417 |
|
919 |
616 |
$24K |
| J1453 |
Injection, fosaprepitant, 1 mg |
742 |
469 |
$24K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
189 |
163 |
$9K |
| 96415 |
|
355 |
239 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,169 |
1,844 |
$4K |
| 96411 |
|
247 |
156 |
$4K |
| 96523 |
|
103 |
75 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,997 |
2,105 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,701 |
1,129 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,009 |
748 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
953 |
707 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
53 |
28 |
$1K |
| J3490 |
Unclassified drugs |
146 |
58 |
$887.97 |
| 99070 |
|
109 |
61 |
$783.18 |
| 96401 |
|
45 |
36 |
$576.16 |
| J9190 |
Injection, fluorouracil, 500 mg |
27 |
13 |
$521.54 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
314 |
180 |
$464.46 |
| 99195 |
|
27 |
26 |
$390.84 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
56 |
41 |
$264.80 |
| 80053 |
Comprehensive metabolic panel |
263 |
209 |
$45.86 |
| 36415 |
Collection of venous blood by venipuncture |
159 |
132 |
$0.00 |